Needham analyst Gil Blum maintains I-MAB (NASDAQ:IMAB) with a Buy and lowers the price target from $72 to $41.
Needham Maintains Buy on I-MAB, Lowers Price Target to $41
Needham analyst Gil Blum maintains I-MAB (NASDAQ:IMAB) with a Buy and lowers the price target from $72 to $41.